Ocugen’s stock climbs as it beats back investor claims on COVID vaccine

Ocugen shares climbed early Friday after a federal appeals court upheld a lower court’s ruling against shareholders who alleged the company misled investors about its COVID-19 vaccine.

Previous post “Green shoots’ in Germany, data shows, as Europe stocks head for longest weekly winning streak since 2012
Next post The U.S. is the top country for millionaires and billionaires